US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.84

-2.5400-1.59%

Volume:8.30M

Turnover:1.30B

Market Cap:10.91B

PE:8.60

High:158.70

Open:157.40

Low:155.82

Close:159.38

52wk High:169.89

52wk Low:92.64

Shares:69.55M

Float Shares:69.55M

Volume Ratio:1.34

T/O Rate:11.94%

Dividend:0.57

Dividend Rate:0.37%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

HCA Healthcare Delivers Consistent Message Around H2 Cadence Expectations, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and MiMedx Group (MDXG)

Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Kelun-Biotech Advances Ultra-Long-Acting Asthma Antibody Into Phase 3 After Positive Data

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Table: SciVision Biotech Aug Rev Nt$66.4m vs Nt$85.9m

Health Care Roundup: Market Talk

Sartorius Stedim Biotech (0RG8) Gets a Buy from Barclays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/XBI/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":156.84,"timestamp":1789069680061,"preClose":159.38,"halted":0,"volume":8301140,"delay":0,"changeRate":-0.015936754925335625,"floatShares":69550000,"shares":69550000,"eps":18.23,"marketStatus":"Trading","change":-2.54,"latestTime":"09-10 15:48:00 EDT","open":157.4,"high":158.7,"low":155.82,"amount":1304015955.2092001,"amplitude":0.01807,"askPrice":156.85,"askSize":253,"bidPrice":156.81,"bidSize":250,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":159.38,"sharesOutstanding":63325000,"nav":161.918202,"aum":11172355927.14,"dividendRate":0.003659,"bidAskSpread":0.0003,"preHourTrading":{"tag":"盘前","latestPrice":157.6,"preClose":159.38,"latestTime":"09:29 EDT","volume":23758,"amount":3759554.06218,"timestamp":1789046999999,"change":-1.78,"changeRate":-0.011168,"amplitude":0.020646},"postHourTrading":{"tag":"盘后","latestPrice":159.35,"preClose":159.38,"latestTime":"19:55 EDT","volume":59882,"amount":9543147.209,"timestamp":1788998149275,"change":-0.03,"changeRate":-0.000188,"amplitude":0.002949},"volumeRatio":1.340151,"impliedVol":0.314,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.340151,"shares":69550000,"dividePrice":0.5738,"high":158.7,"amplitude":0.01807,"preClose":159.38,"low":155.82,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.84,"committee":-0.005964,"eps":18.23,"divideRate":0.003659,"volume":8301140,"delay":0,"ttmEps":18.23,"open":157.4,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":165.37,"twentyDayClose":159.39,"sixtyDayClose":136.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665737976","title":"HCA Healthcare Delivers Consistent Message Around H2 Cadence Expectations, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2665737976","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665737976?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:43","pubTimestamp":1788882197,"startTime":"0","endTime":"0","summary":"HCA Healthcare's (HCA) management delivered a consistent message around second-half cadence expectations, with a more difficult comparison ahead for Q3 and a relatively more favorable comparison for Q","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1084165304.USD","LU1150488218.USD","LU0068578508.USD","SG9999014021.USD","LU1119994496.HKD","LU1201861249.SGD","SG9999014005.SGD","LU0868494617.USD","BK4185","IE00B3S45H60.SGD","IHF","HCA","LABU","LU0878866978.SGD","LU1267930490.SGD","IE00B775SV38.USD","LU1267930573.SGD","LU2355687059.USD","SG9999014013.SGD","BK4504","BK4585","XLV","LU0211327993.USD","SG9999014039.USD","LU0310799852.SGD","LU0985489474.SGD","LU0187121727.USD","LU0708994859.HKD","LU1150488135.SGD","BK4588","LU1261432733.SGD","LU0648001328.SGD","LU0114720955.EUR","LU0882574055.USD","LU0211328371.USD","LU1489326972.SGD","LU0310800379.SGD","LU0130102774.USD","LU0433182093.SGD","LU0203345920.USD","BK4581","LU0029864427.USD","LU0203347892.USD","LU0128525929.USD","LU2244417387.USD","XBI","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375964","title":"Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and MiMedx Group (MDXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375964?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:20","pubTimestamp":1788873611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Establishment Labs Holdings (ESTA) and MiMedx Group ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-establishment-labs-holdings-esta-and-mimedx-group-mdxg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-establishment-labs-holdings-esta-and-mimedx-group-mdxg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU2324357040.USD","ESTA","BK4588","MDXG","XBI","XLV","LABU","BK4139","LU0128526141.USD","BK4198","BK4137","BK4585","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665013373","title":"Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums","url":"https://stock-news.laohu8.com/highlight/detail?id=2665013373","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665013373?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:15","pubTimestamp":1788873300,"startTime":"0","endTime":"0","summary":"Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September CEO Abizer Gaslightwala to deliver keynote a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357752/0/en/akari-therapeutics-selected-to-showcase-novel-ph1-adc-payload-platform-at-leading-global-oncology-adc-and-healthcare-forums.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LENZ","BK4581","HCSG","XBI","XLV","BK4139","LABU","BK4588","LU0128526141.USD","BK4007","LU0029874061.USD","BK4585","BK4539","IEIH","BK4137","CST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373903","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373903?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:02","pubTimestamp":1788872523,"startTime":"0","endTime":"0","summary":"Financial stocks were flat to lower pre-bell Tuesday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  declining by 1.3%.Novartis  stock was down more than 12% after the company said its late-stage study evaluating delpacibart etedesiran in patients with myotonic dystrophy type 1 has failed to meet its primary endpoint of video hand opening time.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","LABU","IE00B2B36J28.USD","LU0320765489.SGD","XLV","PPH","LU0029874061.USD","LU0208291251.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","LU0211331839.USD","LU0128526141.USD","BK4532","IBB","BK4581","HCSG","BK4137","MEDX","IE0002141913.USD","IE0009355771.USD","NVS","BK4585","BK4007","IE00BFTCPJ56.SGD","XBI","BK4588","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373511","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373511?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:51","pubTimestamp":1788871865,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Guardant Health (GH) and Neurocrine (N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0289739699.SGD","GNMX","AMGN","LU1057294990.SGD","LU2242646821.SGD","BK4137","PBE","LU0889565916.HKD","LU0109394709.USD","XLV","IE00BJT1NW94.SGD","BIB","BBH","NBIX","BK4588","LU0154245756.USD","XBI","BK4599","LU0058720904.USD","HELX","BK4534","LU2242652126.USD","GDOC","LU2468319806.SGD","LU0029874061.USD","IBB","PJP","PTH","BK4585","TBXU","BK4535","IE0002141913.USD","GH","HCSG","BK4139","LABU","FFOX","LFSC","IBBQ","BK4533","LU1571399168.USD","LU2065170008.USD","LU0154245673.USD","GNOM","EKG","IE0009355771.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378258","title":"Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378258?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:37","pubTimestamp":1788871052,"startTime":"0","endTime":"0","summary":"Concord Healthcare Group Co., Ltd. Class H ( ($HK:2453) ) just unveiled an announcement. Concord Healthcare Group Co., Ltd. has disclosed that its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","BK4137","LU0029874061.USD","LABU","BK4581","HCSG","CNDA","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378444","title":"PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378444","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378444?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"Dr. Soon-Shiong will Join PDS Biotech’s Board of Directors PDS Biotech Plans toProgressDevelopment of PDS0301ImmunocytokineinSolidTumors PRINCETON, N.J., Sept.  08, 2026 (GLOBE NEWSWIRE) -- PDS Biotec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357657/37149/en/pds-biotech-announces-up-to-22-55-million-financing-led-by-dr-patrick-soon-shiong-founder-of-nantworks.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4588","NCI","BK4124","BK4202","BK4581","MSS","XBI","PATK","BK4113","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378198","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378198?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU1861559042.SGD","BK4137","ARKG","SYNB","BK4139","BK4588","XLV","BK4556","BK4581","LU0128526141.USD","BK4585","CRSP","LU0029874061.USD","HCSG","LU1861558580.USD","LABU","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320058","title":"Kelun-Biotech Advances Ultra-Long-Acting Asthma Antibody Into Phase 3 After Positive Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320058","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320058?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:07","pubTimestamp":1788869264,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( ($HK:6990) ) has shared an update. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kelun-biotech-advances-ultra-long-acting-asthma-antibody-into-phase-3-after-positive-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kelun-biotech-advances-ultra-long-acting-asthma-antibody-into-phase-3-after-positive-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378413","title":"Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378413","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378413?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:00","pubTimestamp":1788868800,"startTime":"0","endTime":"0","summary":"MIAMI, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term va","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357555/28889/en/fortress-biotech-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XBI","BK4588","FBIO","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327109","title":"NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327109","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327109?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:28","pubTimestamp":1788866923,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NovaBridge Biosciences ( ($NBP) ). NovaBridge Biosciences reported on September 8, 2026, that it has appointed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","LABU","LU0128526141.USD","LU0029874061.USD","NBP","BK4588","BK4585","XLV","HCSG","BK4137","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665716322","title":"Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665716322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665716322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of ora","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357480/0/en/atea-pharmaceuticals-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","XBI","HCSG","LABU","BK4137","LU0029874061.USD","LU0128526141.USD","BK4581","AVIR","BK4588","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232230","title":"Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232230?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:50","pubTimestamp":1788864614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dyne Therapeutics (DYN), NewAmsterdam Pharma Company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IONS","XBI","XLV","BK4139","LU0128526141.USD","BK4588","NAMS","BK4505","HCSG","BK4585","BK4137","DYN","BK4581","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322379","title":"Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322379?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864320,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andres Y. Maldonado from H.C. Wainwright...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194569723","title":"TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=1194569723","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194569723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:42","pubTimestamp":1788864140,"startTime":"0","endTime":"0","summary":"TEDA BIOMEDICAL (08189) has announced the signing of a strategic cooperation framework agreement with Hunan Xingchen Universal Robot Co., Ltd. (referred to as \"Xingchen Universal\").Under the terms of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","LABU","BK4588","IXJ","159760","08189","BK4550","XBI","VHT","WDRN","BK1113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000BZT7R73.USD","IHE","GLAM","PBE","RPRX","LU1037948897.HKD","BK4137","LU0417517546.SGD","XBI","MEDX","BK4550","LU0965509010.AUD","LU0211328371.USD","LU0689626769.HKD","XLV","IE0004445239.USD","IXJ","HCSG","LU1551013342.USD","ABBV","LU2237443549.SGD","IE00BVYPNV92.GBP","LABU","LU0553294199.USD","IYH","LU1057294990.SGD","LU0128525929.USD","JDOC","LU1244550494.USD","AGNG","LU1291159041.SGD","LU0823416689.USD","PJP","LU1929549753.HKD","FHLC","IE00B3PB1722.GBP","FTXH","LU0859254822.USD","TRUH","VHT","LU1003077747.HKD","LU0211327993.USD","LU0861579265.USD","LU2433249047.HKD","PPH","SMMT","LU2125909247.SGD","LU0029874061.USD","LU2347655073.USD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329053","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329053?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:50","pubTimestamp":1788861008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Neurosense Therapeutics ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-330?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-330?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0353189763.USD","LU0225283273.USD","LU0029874061.USD","LU1366192091.USD","LU0238689110.USD","LU2506952097.USD","LU0251132253.USD","HCSG","LU0128526141.USD","IE00BJT1NW94.SGD","LU0345769128.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2506951875.HKD","LU1804176565.USD","LU0432979614.USD","BK4504","LU2362541513.USD","LU1791710582.SGD","LU0114720955.EUR","LU2112291526.USD","LU1989771016.USD","LU2324357040.USD","LU1720051017.SGD","LU2362541273.HKD","BK4588","XBI","BK4581","LU1720051108.HKD","LU2357305700.SGD","LU1057294990.SGD","LU0138981039.USD","LU0950375773.USD","SG9999001176.USD","BSX","LU1989764664.SGD","LU2491050154.USD","BK4082","LU2244417387.USD","XLV","SG9999001176.SGD","LU1291159041.SGD","SG9999013999.USD","LABU","LU0823416689.USD","LU0048584097.USD","LU0345769631.USD","LU2491050071.SGD","LU0187121727.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325431","title":"Table: SciVision Biotech Aug Rev Nt$66.4m vs Nt$85.9m","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325431","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325431?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:47","pubTimestamp":1788857220,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665722323","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2665722323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665722323?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:20","pubTimestamp":1788855600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0817 GMT - Novartis's latest clinical-trial failure suggests the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328204","title":"Sartorius Stedim Biotech (0RG8) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328204?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852321,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Buy rating on Sartorius Stedim Biotech today and set a price target of €240.00. According to TipRank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sartorius-stedim-biotech-0rg8-gets-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sartorius-stedim-biotech-0rg8-gets-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CFA","XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":5,"totalSize":364,"code":"91000000","status":"200"}]}}